Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 9.07
+0.25 (2.83%)
Sep 30, 2026, 3:04 PM CST
SHE:002412 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,564 | 3,226 | 3,024 | 3,412 | 3,085 | 3,195 | |
Market Cap Growth | 41.72% | 6.66% | -11.36% | 10.60% | -3.46% | -4.66% |
Enterprise Value | 4,123 | 2,796 | 2,733 | 3,276 | 2,981 | 3,247 |
Last Close Price | 9.07 | 6.12 | 5.74 | 6.47 | 5.59 | 5.79 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 19.33 | 16.28 | 13.73 | 16.64 | 18.40 | 23.70 |
Forward PE | - | 15.12 | 15.12 | 15.12 | 15.12 | 15.12 |
PS Ratio | 4.54 | 3.11 | 3.01 | 3.57 | 3.37 | 3.58 |
PB Ratio | 1.95 | 1.36 | 1.37 | 1.74 | 1.63 | 1.83 |
P/TBV Ratio | 1.99 | 1.38 | 1.40 | 1.78 | 1.67 | 1.94 |
P/FCF Ratio | 25.74 | 13.77 | 25.38 | 24.12 | 23.32 | - |
P/OCF Ratio | 24.16 | 13.15 | 23.12 | 21.20 | 21.45 | 15.03 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.10 | 2.69 | 2.72 | 3.43 | 3.26 | 3.64 |
EV/EBITDA Ratio | 17.10 | 10.04 | 9.86 | 14.62 | 16.13 | 18.31 |
EV/EBIT Ratio | 20.52 | 11.74 | 11.57 | 18.92 | 22.38 | 25.75 |
EV/FCF Ratio | 23.25 | 11.93 | 22.94 | 23.16 | 22.53 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0 | 0.02 | 0.04 | 0.05 | 0.06 | 0.08 |
Debt / EBITDA Ratio | 0.00 | 0.21 | 0.30 | 0.42 | 0.65 | 0.74 |
Debt / FCF Ratio | 0.01 | 0.25 | 0.71 | 0.67 | 0.91 | - |
Net Debt / Equity Ratio | -0.19 | -0.22 | -0.13 | -0.08 | -0.08 | 0.00 |
Net Debt / EBITDA Ratio | -1.83 | -1.89 | -1.04 | -0.71 | -0.87 | -0.04 |
Net Debt / FCF Ratio | -2.49 | -2.24 | -2.41 | -1.13 | -1.22 | 0.46 |
Asset Turnover | 0.40 | 0.40 | 0.41 | 0.41 | 0.42 | 0.45 |
Inventory Turnover | 1.05 | 1.12 | 1.10 | 1.10 | 1.53 | 2.74 |
Quick Ratio | 10.82 | 3.51 | 2.51 | 1.71 | 1.61 | 1.18 |
Current Ratio | 14.79 | 4.58 | 3.53 | 2.52 | 2.28 | 1.53 |
Return on Equity (ROE) | 10.28% | 8.64% | 10.57% | 10.63% | 9.22% | 8.08% |
Return on Assets (ROA) | 5.00% | 5.68% | 6.05% | 4.68% | 3.78% | 3.94% |
Return on Invested Capital (ROIC) | 9.44% | 10.49% | 11.07% | 8.89% | 7.08% | 6.67% |
Return on Capital Employed (ROCE) | 8.50% | 9.90% | 10.60% | 8.70% | 7.00% | 7.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 5.17% | 6.14% | 7.28% | 6.01% | 5.43% | 4.22% |
FCF Yield | 3.88% | 7.26% | 3.94% | 4.15% | 4.29% | -0.53% |
Dividend Yield | 3.31% | 4.90% | - | - | 5.36% | - |
Payout Ratio | 64.43% | 0.87% | 1.16% | 75.44% | 2.43% | 4.88% |
Buyback Yield / Dilution | -0.01% | -0.01% | 0.01% | -0.01% | -0.01% | 0.03% |
Total Shareholder Return | 3.29% | 4.90% | 0.01% | -0.01% | 5.36% | 0.03% |